TradingView
RocketTickers
17 août 2020 16:56
Immunomedics Announces FDA Approval of Samsung Biologics as Anti
Long
NASDAQ:IMMU
15
Description
⋅
17 août 2020 16:56
IMMU: Immunomedics
2020-08-17 08:00:10
Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
Beyond Technical Analysis
Commentaires
aaronsmth5
⋅
18 août 2020 23:33
go to biopharmcatalyst.com and look up all the other big announcements coming, stay long my friend
Plus